Related references
Note: Only part of the references are listed.Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Milagros Gonzales et al.
BMC INFECTIOUS DISEASES (2010)
Management of Clostridium difficile Infection: Thinking Inside and Outside the Box
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2010)
Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection
Mark Miller
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Lack of Increased Colonization with Vancomycin-Resistant Enterococci during Preferential Use of Vancomycin for Treatment during an Outbreak of Healthcare-Associated Clostridium difficile Infection
Mark Miller et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
Gerald W. Tannock et al.
MICROBIOLOGY-SGM (2010)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Review of Current Literature on the Economic Burden of Clostridium difficile Infection
Erik R. Dubberke et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Clostridium difficile-associated diarrhea:: an emerging threat to pregnant women
Nadine G. Rouphael et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease
Wafa N. Al-Nassir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
Les Dethlefsen et al.
PLOS BIOLOGY (2008)
Clostridium aldenense sp nov and Clostridium citroniae sp nov isolated from human clinical infections
Yumi A. Warren et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
In vitro activities of OPT-80 and comparator drugs against intestinal bacteria
SA Finegold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients
A Bhalla et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Share Paper
